Latest filing published 29 Nov 2016 for KalVista Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Joshua Resnick: trading record in brief
Joshua Resnick discloses dealings in KalVista Pharmaceuticals, Inc. to SEC (Form 4). In total, 2 filings cover trades dated 21 November 2016.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 29 November 2016: a share grant, in KalVista Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joshua Resnick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,508,279 sharesCommon StockSEC:0001140361-16-088115:0
- 71,211 sharesCommon StockSEC:0001140361-16-088115:1
2 of 2 declarations
